Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Undergoing Central Line Placement: A Phase 2 Clinical Trial is a research paper published in Arteriosclerosis Thrombosis and Vascular Biology (2023). On theSindex it has a DataRank of 1.0. It has been cited 40 times, with 33 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.557
From this paper's citation signal
Citation Network Contribution
0.454
From 21 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 33 citers.
NHLBI NIH HHS
Grant: R35 HL140025
NHLBI NIH HHS
Grant: R44 HL106919
NIH HHS
Grant: P51 OD011092
NHLBI NIH HHS
Grant: R01 HL101972
NHLBI NIH HHS
Grant: R01 HL151367
FWCI
10.20
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals